• Tyrothricin: Mechanistic Insight and Strategy for Translatio

  2026-07-09

  This thought-leadership article unpacks the dual promise of Tyrothricin—a peptide antibiotic mixture—by linking its membrane-disrupting action with actionable guidance for translational infection research. Integrating mechanistic and workflow insights, it provides researchers with a competitive edge in antimicrobial model development, protocol optimization, and cross-kingdom pathogen control.

• FPR2/ALX Modulation Restricts Autoimmune Astrocytopathy via

  2026-07-09

  The reference study demonstrates that targeted FPR2/ALX receptor stimulation with Quin-C1 modulates microglia and natural killer cell activity to restrict neuroinflammation and reduce CNS demyelination in a mouse model of autoimmune astrocytopathy. These findings uncover new mechanistic links and therapeutic potential for managing neuromyelitis optica spectrum disorders.

• Cefepime (BMY-28142): Applied Workflows for CNS Infection Mo

  2026-07-08

  Cefepime (BMY-28142) enables precise modeling of Gram-positive and Gram-negative bacterial infections, especially in central nervous system (CNS) research. This guide translates benchmarking studies and advanced PKPD modeling into actionable workflows and troubleshooting strategies for optimizing antibiotic resistance and neurotoxicity assays.

• LY-411575: Gamma-Secretase Inhibitor for Advanced Disease Mo

  2026-07-08

  LY-411575 stands out as a potent gamma-secretase inhibitor, enabling precise modulation of amyloid beta production and Notch signaling across Alzheimer’s disease and cancer models. Explore actionable workflows, troubleshooting strategies, and translational insights that set this inhibitor apart for rigorous bench research.

• HyperScribe T7 Cy3 RNA Labeling Kit: Fluorescent Probe Synth

  2026-07-07

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit enables efficient synthesis of Cy3-labeled RNA probes for sensitive detection in molecular biology applications. This kit leverages optimized T7 RNA polymerase transcription and tunable Cy3-UTP incorporation to produce probes suitable for in situ hybridization and Northern blot workflows.

• ATS-9R: Targeted Gene Silencing in Adipocytes for Metabolic

  2026-07-07

  ATS-9R (Adipocyte-targeting sequence-9-arginine) offers precise, efficient, and non-viral gene delivery directly to white adipose tissue, specifically targeting adipocytes and macrophages. Its prohibitin-mediated endocytosis and robust nucleic acid condensation streamline metabolic disease studies, enabling reproducible gene silencing with minimal off-target effects.

• Mitocytosis Inhibition Enhances Mitochondria-Targeted Therap

  2026-07-06

  Deng et al. identify mitocytosis as a key barrier to effective mitochondria-targeted antimetastatic therapy in migratory breast cancer models. Their dual-delivery nanoplatform both damages tumor mitochondria and blocks mitocytosis, significantly improving therapeutic efficacy in aggressive tumors with high migrasome activity.

• Niclosamide in Cancer Research: Advanced STAT3 Inhibition an

  2026-07-06

  Explore how Niclosamide, a potent STAT3 signaling pathway inhibitor, enables refined assay design and interpretation in cancer research. This article uniquely integrates the latest in vitro evaluation innovations and mechanistic insights to empower researchers seeking precise control of proliferation and apoptosis endpoints.

• Clathrin-Mediated Entry of Grass Carp Reovirus: Inhibitor An

  2026-07-05

  Wang et al. (2018) systematically investigated how genotype III grass carp reovirus (GCRV104) enters host cells, revealing a strict dependence on clathrin-mediated endocytosis and endosomal acidification. Their inhibitor-based approach clarifies viral entry mechanisms and highlights the specificity of cellular pathways involved in aquareovirus infection.

• Trifluoperazine 2HCl: Applied Dopamine D2 Receptor Inhibitio

  2026-07-04

  Trifluoperazine 2HCl is transforming both dopaminergic and host-directed antibacterial research by enabling precise dopamine D2 receptor inhibition with robust solubility and reproducibility. This article details hands-on workflows, troubleshooting tips, and experimental strategies that leverage Trifluoperazine 2HCl for advanced neuropharmacology assays and macrophage function studies.

• DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid): Rel

  2026-07-03

  This article explores how DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid, SKU B7675) addresses key challenges in cell viability, cytotoxicity, and proliferation assays. We examine real-world laboratory scenarios, evidence-backed protocol guidance, and vendor selection considerations, providing practical insights for biomedical researchers seeking reproducible and high-sensitivity chloride channel blockade.

• A-1210477: MCL-1 Inhibitor Empowering Apoptosis Assays in Ca

  2026-07-03

  A-1210477 enables precise, selective inhibition of MCL-1, transforming mitochondrial apoptosis assays and cancer cell survival research. This guide navigates optimized protocols, advanced use-cases, and troubleshooting strategies that leverage its unique properties for maximal experimental impact.

• HPF: Precision Detection of hROS in Oxidative Stress Researc

  2026-07-02

  HPF (hydroxyphenyl fluorescein) empowers researchers with accurate, selective detection of highly reactive oxygen species, setting a new benchmark for intracellular oxidative stress visualization. This article delivers actionable workflows, expert troubleshooting, and cutting-edge applications inspired by landmark studies and APExBIO’s trusted product quality.

• BKT140 (BL-8040): Precision Workflows for CXCR4 Antagonism

  2026-07-02

  BKT140 (BL-8040) empowers cancer researchers to dissect and target CXCR4-mediated tumor progression and stem cell mobilization with unmatched specificity. This guide translates the latest theranostic findings into actionable protocols and troubleshooting strategies, making BKT140 indispensable for advanced oncology workflows.

• 3-Methyladenine: Precision Autophagy Inhibition for Translat

  2026-07-01

  Explore the mechanistic foundations and translational opportunities of 3-Methyladenine (3-MA), a selective class III PI3K inhibitor, for autophagy and cancer research. This thought-leadership article integrates recent advances—such as the role of autophagy in neuropathic pain and cancer cell migration—with strategic guidance for protocol design and workflow optimization. Supported by primary literature and competitive insights, it positions 3-MA from APExBIO as a critical tool for next-generation translational discovery.

14643 records 1/977 page Next 12345 下5页 Last page